Population-based analysis reveals increased overdose deaths from polysubstance use in racial and ethnic groups, highlighting significant health disparities.
In the United States from 2004 to 2022, overdose deaths from polysubstance use escalated sharply across all racial and ethnic groups, with disproportionate increases across non-Hispanic Black and Hispanic individuals, particularly in opioid-stimulant and opioid-only profiles.
No takes yet. Share an insight, caveat, or question.
Cadet et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: